Users of statins were 20% less likely to have cancer (adjusted odds ratio, 0.80; 95% CI, 0.660.96) in a case-control study from the Academic Medical Centre, University of Amsterdam, Netherlands, that was presented at the 39th Annual Meeting of the American Society of Clinical Oncology
Get the latest industry news, event updates, and more from Managed healthcare Executive.